London, United Kingdom

Ioannis Papaioannou

This inventor holds 22 USPTO granted patents and 2 published patent applications and 1 EPO patent, primarily in Polysaccharide Chemistry. Top assignee: Lipoxen Technologies Incorporated. Active years: 2010-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ioannis Papaioannou. Retrieved from https://idiyas.com/inventor/ioannis-papaioannou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 22 

% Patents Active = 86.4

 

Average Co-Inventor Count = 3.4

ph-index = 3

Forward Citations = 39(Granted Patents)


Company Filing History:


Years Active: 2010-2019

Loading Chart...
Loading Chart...
Areas of Expertise:
Polysaccharide
Sialic Acid
Protein Derivatisation
Conjugation
Fractionation
Charged Polysaccharide
Polysialic Acid
Activated Derivatives
22 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Ioannis Papaioannou in Polysaccharide Research**

Introduction

Ioannis Papaioannou, an accomplished inventor based in London, GB, has made significant strides in the field of polysaccharide research, securing a total of 22 patents throughout his career. His work focuses on the fractionation of charged polysaccharides and the development of sialic acid derivatives, contributing to advancements in therapeutic applications.

Latest Patents

Among his latest patents is a method for the **fractionation of charged polysaccharides**, where polydisperse and charged polysaccharides are effectively separated into low polydispersity fractions. The process involves using an ion exchange resin in a column and sequential elution with buffers of varying ionic strength and pH. This innovative technique creates preparations that are particularly useful for producing PSA-derivatised therapeutic agents intended for human and animal use.

Another notable patent is focused on **sialic acid derivatives for protein derivatisation and conjugation**. In this invention, derivatives are synthesized from polysaccharides with sialic acid at the reducing terminal end. The reduction leads to aldehyde formation, allowing the derivatives to react with therapeutically beneficial substrates, enhancing drug delivery systems.

Career Highlights

Ioannis is associated with Lipoxen Technologies Incorporated, a company known for its dedication to developing novel therapeutic agents and drug delivery technologies. His expertise in polysaccharide research has played a vital role in driving the company’s innovative projects forward.

Collaborations

Throughout his career, he has collaborated with notable coworkers such as Sanjay Jain and Peter Laing. These collaborations have further enriched his research, allowing for the exchange of ideas and the development of cutting-edge solutions in the field.

Conclusion

Ioannis Papaioannou’s contributions to the field of polysaccharide research through his patents and collaborative efforts signify his pivotal role as an innovator. His work not only enhances the scientific understanding of polysaccharides but also paves the way for the development of important therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…